Cresco Labs (CL) Stock Forecast & Price Target

Compare

200 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CL Analyst Ratings

Strong Buy

3 Buy

0 Hold

0 Sell

Based on 3 analysts giving stock ratings to

Cresco

Labs

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CL Stock 12 Month Forecast

Average Price Target

C$2.41

▲(95.97% Upside)

Based on 3 Wall Street analysts offering 12 month price targets for Cresco Labs in the last 3 months. The average price target is C$2.41 with a high forecast of C$2.75 and a low forecast of C$2.00. The average price target represents a 95.97% change from the last price of C$1.23.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"C$0","1":"C$1","2":"C$2","3":"C$3","-1":"-C$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.75480956,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$2.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.410458365,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$2.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.997236931,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$2.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.17,1.2919084276923076,1.4138168553846153,1.535725283076923,1.6576337107692307,1.7795421384615384,1.9014505661538461,2.023358993846154,2.1452674215384615,2.267175849230769,2.389084276923077,2.5109927046153846,2.6329011323076923,{"y":2.75480956,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.17,1.2654198742307692,1.3608397484615384,1.4562596226923077,1.551679496923077,1.6470993711538462,1.7425192453846154,1.8379391196153847,1.933358993846154,2.028778868076923,2.1241987423076925,2.2196186165384617,2.315038490769231,{"y":2.410458365,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.17,1.233633610076923,1.297267220153846,1.3609008302307692,1.4245344403076923,1.4881680503846153,1.5518016604615386,1.6154352705384616,1.6790688806153846,1.7427024906923076,1.8063361007692307,1.869969710846154,1.933603320923077,{"y":1.997236931,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.13,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.2,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.14,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.32,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.34,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.28,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.99,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.25,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.79,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.86,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.7,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.17,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetC$2.75

Average Price TargetC$2.41

Lowest Price TargetC$2.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Frederico Gomes

ATB Capital Markets

C$2.5

Buy

103.25%

Upside

Upgraded

12/02/25

Cresco Labs upgraded to Outperform from Sector Perform at ATB CapitalCresco Labs upgraded to Outperform from Sector Perform at ATB Capital

Bill Kirk

Roth MKM

C$2.77

Buy

125.28%

Upside

Reiterated

11/06/25

Roth MKM Sticks to Their Buy Rating for Cresco Labs (CRLBF)

Neal Gilmer

Haywood

C$2

Buy

62.60%

Upside

Reiterated

11/05/25

Cresco Labs: Strategic Market Focus and Financial Stability Justify Buy RatingCresco Labs reported Q3/25 financial results that were generally in line with expectations, with better-than-expected gross margins driving EBITDA slightly ahead of forecast. The Company continues to prioritize execution in core markets and balance sheet strength, highlighted by the successful refinancing of its senior credit facility and $6M in operating cash flow generated in the quarter. The completed exit from California simplifies Cresco’s footprint and removes low-margin operations, positioning the Company to focus on its strongest markets and margin expansion opportunities into 2026.

Russell Stanley

Beacon

C$1.75

Buy

42.28%

Upside

Reiterated

08/18/25

Cresco Labs is still undervalued, this analyst saysBeacon Securities analyst Russell Stanley noted August 14 that Cresco Labs (Cresco Labs Stock Quote, Chart, News, Analysts, Financials CSE:CL) has completed its previously announced debt refinancing, closing on a five-year, $325-million senior secured term loan paying 12.5%.

Luke Hannan

Canaccord Genuity

C$2.5→C$1.5

Buy

21.95%

Upside

Reiterated

06/02/25

Cresco Labs downgraded to Speculative Buy from Buy at CanaccordCresco Labs downgraded to Speculative Buy from Buy at Canaccord

Jesse Pytlak

Cormark Securities

C$1.75

Buy

42.28%

Upside

Upgraded

03/17/25

Cresco Labs upgraded to Speculative Buy from Market Perform at CormarkCresco Labs upgraded to Speculative Buy from Market Perform at Cormark

Aaron Grey

Alliance Global Partners

C$3.5→C$3.25

Buy

164.23%

Upside

Reiterated

03/12/25

Cresco Labs price target lowered to C$3.25 from C$3.50 at Alliance GlobalCresco Labs price target lowered to C$3.25 from C$3.50 at Alliance Global

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Frederico Gomes

ATB Capital Markets

C$2.5

Buy

103.25%

Upside

Upgraded

12/02/25

Cresco Labs upgraded to Outperform from Sector Perform at ATB CapitalCresco Labs upgraded to Outperform from Sector Perform at ATB Capital

Bill Kirk

Roth MKM

C$2.77

Buy

125.28%

Upside

Reiterated

11/06/25

Roth MKM Sticks to Their Buy Rating for Cresco Labs (CRLBF)

Neal Gilmer

Haywood

C$2

Buy

62.60%

Upside

Reiterated

11/05/25

Russell Stanley

Beacon

C$1.75

Buy

42.28%

Upside

Reiterated

08/18/25

Luke Hannan

Canaccord Genuity

C$2.5→C$1.5

Buy

21.95%

Upside

Reiterated

06/02/25

Cresco Labs downgraded to Speculative Buy from Buy at CanaccordCresco Labs downgraded to Speculative Buy from Buy at Canaccord

Jesse Pytlak

Cormark Securities

C$1.75

Buy

42.28%

Upside

Upgraded

03/17/25

Cresco Labs upgraded to Speculative Buy from Market Perform at CormarkCresco Labs upgraded to Speculative Buy from Market Perform at Cormark

Aaron Grey

Alliance Global Partners

C$3.5→C$3.25

Buy

164.23%

Upside

Reiterated

03/12/25

Cresco Labs price target lowered to C$3.25 from C$3.50 at Alliance GlobalCresco Labs price target lowered to C$3.25 from C$3.50 at Alliance Global

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cresco Labs

1 Month

xxx

Success Rate

7/12 ratings generated profit

Average Return

+3.33%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 58.33% of your transactions generating a profit, with an average return of +3.33% per trade.

3 Months

xxx

Success Rate

5/15 ratings generated profit

Average Return

+5.74%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +5.74% per trade.

1 Year

Neal GilmerHaywood

Success Rate

7/15 ratings generated profit

Average Return

-10.83%

reiterated a buy rating last month

Copying Neal Gilmer's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of -10.83% per trade.

2 Years

xxx

Success Rate

10/12 ratings generated profit

Average Return

+28.01%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +28.01% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CL Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CL has received 6 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. CL average Analyst price target in the past 3 months is 2.41.

Each month's total comprises the sum of three months' worth of ratings.

CL Financial Forecast

CL Earnings Forecast

Next quarter’s earnings estimate for CL is -C$0.02 with a range of -C$0.04 to C$0.01. The previous quarter’s EPS was -C$0.07. CL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year CL has Performed in-line its overall industry.

CL Sales Forecast

Next quarter’s sales forecast for CL is C$222.34M with a range of C$219.33M to C$227.88M. The previous quarter’s sales results were C$227.14M. CL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year CL has Performed in-line its overall industry.

CL Stock Forecast FAQ

What is TSE:CL’s average 12-month price target, according to analysts?

Based on analyst ratings, Cresco Labs OTC’s 12-month average price target is 2.41.

What is TSE:CL’s upside potential, based on the analysts’ average price target?

Cresco Labs OTC has 95.97% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TSE:CL a Buy, Sell or Hold?

Cresco Labs OTC has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.

What is Cresco Labs OTC’s price target?

The average price target for Cresco Labs OTC is 2.41. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$2.75 ,the lowest forecast is C$2.00. The average price target represents 95.97% Increase from the current price of C$1.23.

What do analysts say about Cresco Labs OTC?

Cresco Labs OTC’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.

How can I buy shares of TSE:CL?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Cresco Labs (CL) Stock Forecast & Price Target

CL Analyst Ratings

CL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cresco Labs

CL Analyst Recommendation Trends

CL Financial Forecast

CL Earnings Forecast

CL Sales Forecast

CL Stock Forecast FAQ

Detailed List of Analyst Forecasts